Jump to content

Page values for "Clonidine"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringClonidine
brandStringKapvay (ER, ADHD), Catapres (IR, antihypertensive), Catapres-TTS (transdermal patch), Duraclon (epidural injection)
structureFile
classesList of String, delimiter: ,[[:Category:Alpha-2 adrenergic agonists|Alpha-2 adrenergic agonist]] [[:Category:ADHD medicines|ADHD medicine]] [[:Category:Antihypertensives|Antihypertensive]] [[:Category:Opioid withdrawal medicines|Opioid withdrawal medicine]]
mechanismString
usesString'"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"'
starting_doseStringADHD (Kapvay ER): 0.1 mg PO at bedtime, titrate weekly to 0.4 mg/day divided BID. HTN (IR): 0.1 mg PO BID, titrate by 0.1 mg increments
preparationsStringIR tablets 0.1, 0.2, 0.3 mg; ER tablets 0.1, 0.2 mg (Kapvay); transdermal patches 0.1, 0.2, 0.3 mg/24h (TTS-1/2/3, weekly); epidural injection (Duraclon)
fda_maxString2.4 mg/day (HTN, IR); 0.4 mg/day (ADHD, Kapvay)
pill_idText
routesList of String, delimiter: ,Oral transdermal epidural injection
onsetString30-60 min (IR oral); 2-3 days to steady state (transdermal patch)
durationString8-12 hours (IR); ~7 days (transdermal patch)
halflifeString12-16 hours'"`UNIQ--ref-00000026-QINU`"'
bioavailabilityString~75-85% (oral); ~60% (transdermal at steady state)'"`UNIQ--ref-00000027-QINU`"'
pregnancyStringOlder agent with substantial use experience but limited controlled data; case reports of neonatal sedation and transient hypertension with maternal use near term.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Not a controlled substance, like guanfacine and unlike the psychostimulant alternatives for ADHD'"`UNIQ--ref-00000028-QINU`"'